Stay up-to-date with current information and resources

Register with cardeneiv.com and you'll receive valuable information and resources, as they become available, to keep you current and help ensure you can meet the treatment needs of your patients.

Register for Updates

For US Healthcare Professionals Only

Safety and tolerability of ready-to-use CARDENE® I.V. (nicardipine hydrochloride) in clinical trials

Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice. The adverse reaction information does, however, provide a basis for identifying the adverse events that appear to be related to drug use and for approximating rates.

Two hundred forty-four patients participated in 2 multicenter, double-blind, placebo-controlled trials of CARDENE I.V.1

The information on this site is only intended for US Healthcare Professionals

I am a US Healthcare Professional

Continue

I am NOT a US Healthcare Professional

Return